These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15906350)

  • 1. Plasma Epstein-Barr virus (EBV) DNA: role as a screening test for nasopharyngeal carcinoma (NPC)?
    Wong LP; Lai KT; Tsui E; Kwong KH; Tsang RH; Ma ES
    Int J Cancer; 2005 Nov; 117(3):515-6. PubMed ID: 15906350
    [No Abstract]   [Full Text] [Related]  

  • 2. Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program.
    Chan KC; Hung EC; Woo JK; Chan PK; Leung SF; Lai FP; Cheng AS; Yeung SW; Chan YW; Tsui TK; Kwok JS; King AD; Chan AT; van Hasselt AC; Lo YM
    Cancer; 2013 May; 119(10):1838-44. PubMed ID: 23436393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Epstein-Barr virus DNA in serum or plasma for nasopharyngeal cancer: a meta-analysis.
    Liu Y; Fang Z; Liu L; Yang S; Zhang L
    Genet Test Mol Biomarkers; 2011; 15(7-8):495-502. PubMed ID: 21410354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma].
    Cao SM; Min HQ; Gao JS; Hong MH; Xiao XB; Zhang CQ; Liu XD; Zhang AL; Guo X
    Ai Zheng; 2003 Mar; 22(3):302-6. PubMed ID: 12654192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Epstein-Barr virus DNA in plasma/serum: a useful serological indicator for diagnosis of nasopharyngeal carcinoma.
    Mai S; Zong Y; Zhang M; Zhong B; Lin S
    Chin Med J (Engl); 2002 Dec; 115(12):1895-7. PubMed ID: 12622949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Real-time quantitative PCR assay of Epstein-Barr virus in whole blood cells of nasopharyngeal carcinoma patients].
    Wang H; Deng L; Chen SH; Wang SQ; Cao Y
    Shi Yan Sheng Wu Xue Bao; 2003 Feb; 36(1):32-6. PubMed ID: 12751207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma.
    Lo YM; Chan LY; Lo KW; Leung SF; Zhang J; Chan AT; Lee JC; Hjelm NM; Johnson PJ; Huang DP
    Cancer Res; 1999 Mar; 59(6):1188-91. PubMed ID: 10096545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review on Epstein-Barr virus (EBV) DNA in diagnosis of nasopharyngeal carcinoma in Asian populations.
    Han BL; Xu XY; Zhang CZ; Wu JJ; Han CF; Wang H; Wang X; Wang GS; Yang SJ; Xie Y
    Asian Pac J Cancer Prev; 2012; 13(6):2577-81. PubMed ID: 22938423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
    Leung SF; Chan AT; Zee B; Ma B; Chan LY; Johnson PJ; Lo YM
    Cancer; 2003 Jul; 98(2):288-91. PubMed ID: 12872347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Epstein-Barr virus immunoglobulin A and DNA for nasopharyngeal carcinoma screening in the United States.
    O TM; Yu G; Hu K; Li JC
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):992-7. PubMed ID: 17547994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum EBV DNA as a biomarker in primary nasopharyngeal carcinoma of Indian origin.
    Krishna SM; James S; Kattoor J; Balaram P
    Jpn J Clin Oncol; 2004 Jun; 34(6):307-11. PubMed ID: 15333681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of circulating plasma/serum EBV DNA in the clinical management of nasopharyngeal carcinoma.
    Yip TT; Ngan RK; Fong AH; Law SC
    Oral Oncol; 2014 Jun; 50(6):527-38. PubMed ID: 24440146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Assay of Epstein-Barr virus in nasopharyngeal tissues and serum of patients with nasopharyngeal carcinoma].
    Li XM; Yang CZ; Chen PJ; Su ZL; Song Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Sep; 14(9):400-1. PubMed ID: 12563909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein-Barr virus DNA.
    Hong RL; Lin CY; Ting LL; Ko JY; Hsu MM
    Cancer; 2004 Apr; 100(7):1429-37. PubMed ID: 15042677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus serology in early detection and screening of nasopharyngeal carcinoma.
    Ng MH; Chan KH; Ng SP; Zong YS
    Ai Zheng; 2006 Feb; 25(2):250-6. PubMed ID: 16480597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
    Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY
    Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma.
    Tan EL; Looi LM; Sam CK
    Singapore Med J; 2006 Sep; 47(9):803-7. PubMed ID: 16924363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel application of plasma and cerebrospinal fluid level of epstein barr virus DNA in the diagnosis of leptomeningeal metastasis from nasopharyngeal carcinoma. A case report.
    Ma AT; Ma BB; Teo PM; Chan AT
    Oncology; 2008; 74(1-2):119-22. PubMed ID: 18547967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
    Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
    Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.